• Unique and joint associations of polygenic risk for major depression and opioid use disorder with endogenous opioid system function
  Published on 2022-05-11
  3 years ago
• Correction to: Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trial
  Published on 2022-05-11
  3 years ago
• Genetic evidence for a potential causal relationship between insomnia symptoms and suicidal behavior: a Mendelian randomization study
  Published on 2022-05-10
  3 years ago
• Shisa7 phosphorylation regulates GABAergic transmission and neurodevelopmental behaviors
  Published on 2022-05-09
  3 years ago
• In Memoriam—Charles L. Bowden, MD
  Published on 2022-05-09
  3 years ago
• Effects of pharmacological and genetic regulation of COMT activity in alcohol use disorder: a randomized, placebo-controlled trial of tolcapone
  Published on 2022-05-06
  3 years ago
• A role for α7 nicotinic receptors in promoting stress resilience in female mice
  Published on 2022-05-04
  3 years ago

« Previous 1 … 117 118 119 120 121 … 143 Next »

• Risk of readmission in patients with schizophrenia and schizoaffective disorder newly prescribed clozapine
  Published on 2019-01-08
  6 years ago
• The pharmacological management of acute behavioural disturbance: Data from a clinical audit conducted in UK mental health services
  Published on 2018-12-19
  7 years ago
• The effect of dose expectancies on caffeine withdrawal symptoms during tapered dose reduction
  Published on 2018-12-11
  7 years ago
• Cannabidiol regulates the expression of hypothalamus-pituitary-adrenal axis-related genes in response to acute restraint stress
  Published on 2018-10-16
  7 years ago
• Acute ingestion of rosemary water: Evidence of cognitive and cerebrovascular effects in healthy adults
  Published on 2018-10-15
  7 years ago
• A randomized, double-blind, placebo-controlled, crossover study to evaluate the human abuse liability of solriamfetol, a selective dopamine and norepinephrine reuptake inhibitor
  Published on 2018-10-01
  7 years ago
• Clinical pharmacokinetics, pharmacodynamics, safety, and tolerability of JNJ-54175446, a brain permeable P2X7 antagonist, in a randomised single-ascending dose study in healthy participants
  Published on 2018-09-27
  7 years ago

« Previous 1 … 117 118 119 120 121 … 123 Next »

• Towards precision medicine: What are the stratification hypotheses to identify homogeneous inflammatory subgroups
  Published on 2020-11-25
  5 years ago
• ECNP Calendar of Meetings
  Published on 2020-11-25
  5 years ago
• P.796 Therapeutic management of young patients with schizoaffective disorder and alcohol use disorder dual diagnosis
  Published on 2020-11-25
  5 years ago
• P.750 Impact of co-administration of 5-HT6 receptor ligands with haloperidol on MK-801-induced social impairments in rats
  Published on 2020-11-25
  5 years ago
• P.815Endogenous neuropeptide cycloprolylglycine involves in regulation of HIF-1-dependent pathway
  Published on 2020-11-25
  5 years ago
• Chronic nicotine, but not suramin or resveratrol, partially remediates the mania-like profile of dopamine transporter knockdown mice
  Published on 2020-11-25
  5 years ago
• P.774 Olfactory reference syndrome as a prodrome of Alzheimer disease
  Published on 2020-11-25
  5 years ago

« Previous 1 … 117 118 119 120 121 … 144 Next »